Clinical Research Pharmacies and Clinical Trials - Permits and Ownership
Approved by the Governor - Chapter 206
Summary
The law authorizes the Maryland Board of Pharmacy to issue permits for pharmacies that operate solely for clinical research. It allows licensed health‑care providers to hold ownership stakes in such pharmacies, provided a pharmacist is on‑site at all times and the provider does not refer patients for remuneration. The measure also removes clinical‑trial activities from the legal definition of practicing medicine, so they are not subject to standard medical licensing rules.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SB 778 changes status, plus AI-powered summaries and stage predictions.
Sign up free